Company:  CORD BLOOD AMERICA, INC. (CBAI)
Form Type:  DEF 14A
Filing Date:  4/16/2018 
CIK:  0001289496 
Address:  1857 HELM DRIVE 
City, State, Zip:  LAS VEGAS, Nevada 89119 
Telephone:  (702) 914-7250 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.00  
Change: 
0.00 (-5.26%)  
Trade Time: 
Apr 25  
Market Cap: 
$5.09M
Trade CBAI now with

© 2018  
Description of Business
On February 7, 2018, Cord Blood America, Inc. ("CBAI" or the "Company" or "We") announced that it entered into an Asset Purchase Agreement, dated as of February 6, 2018 (the "Purchase Agreement"), with California Cryobank Stem Cell Services LLC ("FamilyCord"). Pursuant to the terms of the Purchase Agreement, FamilyCord agreed to acquire from CBAI substantially all of the assets of CBAI and its wholly-owned subsidiaries and to assume certain liabilities of CBAI and its wholly-owned subsidiaries. The sale does not include CBAI's cash and certain other excluded assets and liabilities. FamilyCord agreed to pay a purchase price of $15,500,000 in cash at closing with $3,000,000 of the purchase price deposited into escrow to secure CBAI's indemnification obligations under the Purchase Agreement. The sale, which is subject to the closing conditions described below, is expected to close as soon as practicable, but likely during the second quarter of 2018.
Register and access this filing in:     
  FORM DEF 14A
    NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
    PROXY STATEMENT
    PROPOSAL NO. 1 - SALE
    PROPOSAL NO. 2 - NAME CHANGE
    PROPOSAL NO. 3 - PROTECTIVE AMENDMENT
    PROPOSAL NO. 4 - ADJOURNMENT
      BENEFICIAL OWNERS
    Other Matters
    SHAREHOLDER PROPOSALS FOR 2018 ANNUAL MEETING
    THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS ...